Login
Home
Charts
Search
Watchlist
Products

Hamps Bio Limited

HAMPS·BSE
₹20.97-8.63%Tue, 22 Sept '26 13:12
Industry:Trading
Indices:

Hamps Bio Limited

HAMPS
BSE
₹20.97
-8.63%
|Tue, 22 Sept '26 13:12
SOICxStockScans Reports
Industry
Trading
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹18Cr
Close
Close Price
₹20.97
Industry
Industry
Trading
PE
Price To Earnings
—
PS
Price To Sales
2.16
Revenue
Revenue
₹8Cr
Rev Gr TTM
Revenue Growth TTM
27.06%
PAT Gr TTM
PAT Growth TTM
-346.23%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
4344
Growth YoY
Revenue Growth YoY%
12.743.1
Expenses
ExpensesCr
3345
Operating Profit
Operating ProfitCr
1000
OPM
OPM%
15.57.04.5-3.4
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0001
PBT
PBTCr
1000
Tax
TaxCr
0000
PAT
PATCr
000-1
Growth YoY
PAT Growth YoY%
-174.1-1,900.0
NPM
NPM%
7.61.0-5.0-12.1
EPS
EPS₹
0.00.00.0-0.6
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
4344
Growth YoY
Revenue Growth YoY%
12.743.1
Expenses
ExpensesCr
3345
Operating Profit
Operating ProfitCr
1000
OPM
OPM%
15.57.04.5-3.4
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0000
Depreciation
DepreciationCr
0001
PBT
PBTCr
1000
Tax
TaxCr
0000
PAT
PATCr
000-1
Growth YoY
PAT Growth YoY%
-174.1-1,900.0
NPM
NPM%
7.61.0-5.0-12.1
EPS
EPS₹
0.00.00.0-0.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
78
Growth
Revenue Growth%
27.1
Expenses
ExpensesCr
68
Operating Profit
Operating ProfitCr
10
OPM
OPM%
11.50.4
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
01
PBT
PBTCr
0-1
Tax
TaxCr
00
PAT
PATCr
0-1
Growth
PAT Growth%
-348.1
NPM
NPM%
4.5-8.7
EPS
EPS₹
0.3-0.8
Financial YearMar 2025Mar 2026
Revenue
RevenueCr
78
Growth
Revenue Growth%
27.1
Expenses
ExpensesCr
68
Operating Profit
Operating ProfitCr
10
OPM
OPM%
11.50.4
Other Income
Other IncomeCr
00
Interest Expense
Interest ExpenseCr
00
Depreciation
DepreciationCr
01
PBT
PBTCr
0-1
Tax
TaxCr
00
PAT
PATCr
0-1
Growth
PAT Growth%
-348.1
NPM
NPM%
4.5-8.7
EPS
EPS₹
0.3-0.8

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
49
Reserves
ReservesCr
4-1
Current Liabilities
Current LiabilitiesCr
24
Non Current Liabilities
Non Current LiabilitiesCr
24
Total Liabilities
Total LiabilitiesCr
1316
Current Assets
Current AssetsCr
45
Non Current Assets
Non Current AssetsCr
811
Total Assets
Total AssetsCr
1316
Financial YearMar 2025Mar 2026
Equity Capital
Equity CapitalCr
49
Reserves
ReservesCr
4-1
Current Liabilities
Current LiabilitiesCr
24
Non Current Liabilities
Non Current LiabilitiesCr
24
Total Liabilities
Total LiabilitiesCr
1316
Current Assets
Current AssetsCr
45
Non Current Assets
Non Current AssetsCr
811
Total Assets
Total AssetsCr
1316

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-2-1
Investing Cash Flow
Investing Cash FlowCr
-6-3
Financing Cash Flow
Financing Cash FlowCr
84
Net Cash Flow
Net Cash FlowCr
00
Free Cash Flow
Free Cash FlowCr
-5-6
CFO To PAT
CFO To PAT%
-591.596.5
CFO To EBITDA
CFO To EBITDA%
-228.9-2,121.1
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-2-1
Investing Cash Flow
Investing Cash FlowCr
-6-3
Financing Cash Flow
Financing Cash FlowCr
84
Net Cash Flow
Net Cash FlowCr
00
Free Cash Flow
Free Cash FlowCr
-5-6
CFO To PAT
CFO To PAT%
-591.596.5
CFO To EBITDA
CFO To EBITDA%
-228.9-2,121.1

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
191418
Price To Earnings
Price To Earnings
62.9
Price To Sales
Price To Sales
2.81.72.2
Price To Book
Price To Book
2.11.82.3
EV To EBITDA
EV To EBITDA
27.9629.0794.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
58.147.147.1
OPM
OPM%
11.50.40.4
NPM
NPM%
4.5-8.7-8.7
ROCE
ROCE%
4.6-3.0-3.0
ROE
ROE%
3.4-9.1-9.1
ROA
ROA%
2.3-4.6-4.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
191418
Price To Earnings
Price To Earnings
62.9
Price To Sales
Price To Sales
2.81.72.2
Price To Book
Price To Book
2.11.82.3
EV To EBITDA
EV To EBITDA
27.9629.0794.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
58.147.147.1
OPM
OPM%
11.50.40.4
NPM
NPM%
4.5-8.7-8.7
ROCE
ROCE%
4.6-3.0-3.0
ROE
ROE%
3.4-9.1-9.1
ROA
ROA%
2.3-4.6-4.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Hamps Bio Limited

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/xwbfy3im6e52vpdcvlvnvv7x.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/o3204ah3wnz78ck14qa9vn3v.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/x665cpyfj1bnt47f1rz0771l.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/hoio0aiyz5npbxh9hwt0dyw6.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/kjjets0vwtc2zd74ytocsm6w.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies